|
FRYL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.630600004494E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.09399974926816E-10 |
| Normal-vs-Stage2 |
3.035600E-03 |
| Normal-vs-Stage3 |
5.448700E-04 |
| Normal-vs-Stage4 |
5.462500E-03 |
| Stage1-vs-Stage2 |
3.820600E-01 |
| Stage1-vs-Stage3 |
1.568260E-02 |
| Stage1-vs-Stage4 |
5.018000E-03 |
| Stage2-vs-Stage3 |
4.721200E-01 |
| Stage2-vs-Stage4 |
3.147400E-01 |
| Stage3-vs-Stage4 |
6.564200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44030000148732E-08 |
| Normal-vs-AfricanAmerican |
3.201800E-02 |
| Normal-vs-Asian |
1.264860E-03 |
| Caucasian-vs-AfricanAmerican |
8.804500E-02 |
| Caucasian-vs-Asian |
3.575600E-01 |
| AfricanAmerican-vs-Asian |
1.082210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15810000000938E-06 |
| Normal-vs-Female |
4.87689999495444E-09 |
| Male-vs-Female |
8.145900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.574300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.55709997620812E-09 |
| Normal-vs-Age(61-80Yrs) |
2.19030000003784E-06 |
| Normal-vs-Age(81-100Yrs) |
3.192600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.741640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.372800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.369600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.927600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.095600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.291160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.68030000002872E-06 |
| Normal-vs-Grade 2 |
2.31950014750737E-10 |
| Normal-vs-Grade 3 |
2.381700E-04 |
| Normal-vs-Grade 4 |
2.184100E-02 |
| Grade 1-vs-Grade 2 |
2.876400E-01 |
| Grade 1-vs-Grade 3 |
4.542100E-03 |
| Grade 1-vs-Grade 4 |
6.602200E-03 |
| Grade 2-vs-Grade 3 |
4.825300E-04 |
| Grade 2-vs-Grade 4 |
3.358200E-03 |
| Grade 3-vs-Grade 4 |
4.242000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.36215516433458E-12 |
| Normal-vs-ccB subtype |
1.583410E-04 |
| ccA subtype-vs-ccB subtype |
8.645000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33330000040566E-07 |
| Normal-vs-N1 |
3.528200E-02 |
| N0-vs-N1 |
6.395200E-01 |
|
|
